Prevalence of Demodex Blepharitis in Japan and Europe

An expert discusses the prevalence and clinical impact of Demodex blepharitis across Japan and Europe, highlighting regional differences in diagnosis and awareness.

Prof. Nanavaty outlines Demodex blepharitis, highlights colorette counts as a measure of severity, and emphasizes that despite its high prevalence in patients, it is frequently overlooked and should be routinely assessed during eye exams.

Prof. Nanavaty reviews UK treatment practices, emphasizing that the lack of Demodex-specific therapies leads to mismanagement, increased healthcare burden, and complications, while highlighting the need for better diagnosis and targeted treatment.